Production (Stage)
Bio-Techne Corporation
TECH
$46.78
-$0.54-1.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.21B | 1.20B | 1.17B | 1.16B | 1.15B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.21B | 1.20B | 1.17B | 1.16B | 1.15B |
| Cost of Revenue | 407.10M | 404.01M | 398.40M | 388.61M | 380.84M |
| Gross Profit | 801.67M | 792.00M | 773.19M | 770.45M | 773.45M |
| SG&A Expenses | 489.08M | 447.37M | 434.32M | 430.01M | 418.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 990.21M | 950.02M | 929.26M | 915.28M | 895.74M |
| Operating Income | 218.56M | 246.00M | 242.33M | 243.78M | 258.54M |
| Income Before Tax | 162.98M | 185.79M | 176.30M | 185.69M | 232.35M |
| Income Tax Expenses | 31.32M | 27.66M | 25.59M | 17.59M | 29.34M |
| Earnings from Continuing Operations | 131.67 | 158.14 | 150.71 | 168.11 | 203.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | 0.00 |
| Net Income | 131.67M | 158.14M | 150.71M | 168.11M | 203.00M |
| EBIT | 218.56M | 246.00M | 242.33M | 243.78M | 258.54M |
| EBITDA | 329.41M | 356.59M | 353.64M | 355.49M | 369.12M |
| EPS Basic | 0.83 | 1.00 | 0.96 | 1.07 | 1.29 |
| Normalized Basic EPS | 0.83 | 0.92 | 0.91 | 0.88 | 0.94 |
| EPS Diluted | 0.83 | 1.00 | 0.95 | 1.05 | 1.25 |
| Normalized Diluted EPS | 0.82 | 0.90 | 0.89 | 0.87 | 0.92 |
| Average Basic Shares Outstanding | 632.20M | 632.14M | 631.24M | 630.84M | 630.48M |
| Average Diluted Shares Outstanding | 641.34M | 642.89M | 642.32M | 643.15M | 644.42M |
| Dividend Per Share | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
| Payout Ratio | 38.45% | 32.02% | 33.48% | 29.99% | 24.82% |